Leerink Swann Begins Coverage on Intersect ENT (XENT)
Equities researchers at Leerink Swann initiated coverage on shares of Intersect ENT (NASDAQ:XENT) in a research report issued on Monday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating and a $20.00 price target on the stock.
Intersect ENT (NASDAQ:XENT) opened at 15.555 on Monday. Intersect ENT has a 52-week low of $12.02 and a 52-week high of $15.77. The stock’s 50-day moving average is $13.24 and its 200-day moving average is $13.24. The company’s market cap is $350.0 million.
Separately, analysts at Piper Jaffray initiated coverage on shares of Intersect ENT in a research note on Monday. They set an “overweight” rating and a $20.00 price target on the stock.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.